|
Nexstim’s navigated brain
stimulation for neurosurgery planning receives FDA approval
Nexstim Oy, a medical device company has received US FDA appproval for
its navigated brain stimulation system for use in the assessment of the
primary motor cortex for pre-procedural planning. 17 December 2009
ATS Medical gains CE approval for
ATS 3f Enable aortic valve
platform that combines the novel 3f tubular pericardial valve design
with its superior hemodynamic profiles and a self-expanding frame to
hold the valve in its optimal position. 17 Dec 2009
European 'incubator' to accelerate
medical device development launched
The European Medical Device Accelerator (MDA) based at the Science Park
next to Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland,
aims to accelerate the development of revolutionary medical device
technology ideas in Europe. 15 December 2009
Lifebridge gains FDA clearance for
cardio-pulmonary support device
German-based Lifebridge AG has received clearance from the US FDA for a
compact, lightweight, mobile heart-lung machine, a first for any
manufacturer worldwide. 15 Dec 2009
Open source initiative offers
cheaper, rapid development path for medical devices
A unique medical innovation initiative launched by Cranfield University
could shape the way the medical device sector introduces new
innovations. 4 December 2009
Toumaz Technology named emerging
technology company of the year
Toumaz Technology Limited, producer of ultra-low power wireless
infrastructure for body monitoring solutions has been named “Emerging
Technology Company of the Year” by the National Microelectronics
Institute (NMI), the premier trade association representing the
semiconductor industry in the UK and Ireland.
Nolato Medical expands Swedish
Technology Centre
Nolato Medical is expanding its Technology Centre in southern Sweden to
meet increased demand from its customers for more complex medical device
product development. 25 Nov 2009
Olympus opens technology centre for
high energy medical products in Czech Republic
Olympus subsidiary Olympus Winter & Ibe has opened a new
technology centre in the Czech city of Přerov to manufacture products
such as high-frequency generators, applicators for bipolar
high-frequency ablation, electrodes for urology, and electrical
instruments used in surgery.
PPD to Acquire Excel PharmaStudies
Global contract research organization PPD, Inc. is to acquire Chinese
company Excel PharmaStudies, Inc. a market leader and one of the largest
contract research organizations in China. 12 November 2009
Manhattan Scientifics and Senior
Scientifics collaborate to develop cancer cell detection system
Manhattan Scientifics and Senior Scientific, LLC are co-operating to
commercialize Senior Scientific’s magnetic needle leukemia cancer cell
detection invention based on the use of nanoparticles. 12 November 2009
Agilent and Stanford University to
build breakthrough sub 10 nanometre scale devices
Agilent Technologies Inc. (NYSE: A) is collaborating with Stanford
University to study using scanning probe microscope and atomic layer
deposition to build devices with breakthroughs in sub 10 nm scale 12.
November 2009
Boston Scientific launches Promus
Element Stent System in Europe
Boston Scientific has announced EU approval and the launch in Europe of
its Promus Element Everolimus-eluting coronary stent system. 3 Nov 2009
Abbott completes acquisition of
Evalve
Abbott (NYSE:ABT) has announced that it has completed its acquisition of
Evalve, Inc., a developer of devices for minimally invasive repair of
mitral valves. 3 Nov 2009
Eurogentec to acquire proteomics
developer AnaSpec
Belgian biotechnology lab products supplier Eurogentec S.A. has
announced it has entered a final agreement for the acquisition of
california protemics developer AnaSpec, Inc. 30 October 2009
Microbix and Hunan
Biopharmaceutical to build Asia's largest flu vaccine facility
Canadian vaccine technology company Microbix, has signed a joint venture
agreement with the Hunan Biopharmaceutical Co. Ltd. for initial
financing to construct a vaccine production facility with capacity for
100m doses of seasonal flu and 300m doses of pandemic flu. 27 Oct 2009
Sinovac obtains third H1N1 vaccine
order from Chinese Government
Sinovac Biotech Ltd. (NYSE:SVA), a leading provider of biopharmaceutical
products in China, has received its third purchase order for its H1N1
vaccine, PANFLU.1, from China's Ministry of Industry and Information
Technology for the national stockpiling plan. 29 Oct 2009
eBioscience acquires Bender
MedSystems' immunoassay technology
eBioscience Corporation has acquired privately held Austrian immunoassay
technology pioneer Bender MedSystems GmbH in an all cash transaction. 29
Oct 2009
GE Launches $250m Healthymagination
Fund for healthcare technology ventures
GE's new equity fund will make investments in highly promising
healthcare technology companies globally that have innovative
diagnostic, IT, and life sciences technologies. 27 October 2009
Siemens integrates Trumpf’s OR
table in its Artis angiography systems
Siemens Healthcare has integrated the TruSystem7500 operating table from
Trumpf with its C-arm systems Artis zee ceiling and Artis zeego. 27
October 2009
Devlin Electronics to launch
Medical division at Medica
Devlin Medical will be launched at the Medica Exhibition in Dusseldorf
in November (18-21). Devlin Medical is dedicated to the development of
innovative point-of-care computing systems. 27 October 2009.
3M Drug Delivery Systems expands
with new Singapore lab
The Singapore lab will develop products in both the inhalation and
transdermal drug-delivery categories for pharmaceutical customers and
patients in the Asia Pacific region. 23 October 2009
Kinaxo and Bayer Vital collaborate in
cancer biomarker identification
Kinaxo will apply its quantitative phosphoproteomics technology
PhosphoScout for the identification of novel biomarkers in a clinical
trial conducted by Bayer Vital. 21 Oct 2009
Siemens wins $135 million service contract
from US health system
The University of Pennsylvania Health System has awarded Siemens
Healthcare a $135 million
contract for integrated service management for diagnostic systems and bio-medical
devices. 21 Oct 2009 Deutsch
Medifacts wins $2.7m contract for
cardiac monitoring in clinical trial
Medifacts International Inc, has been awarded the contract to provide
comprehensive cardiac safety and efficacy services for a large
late-stage clinical trial. 20 Oct 2009
Medical Equipment Industry Deals Analysis — September 2009
An essential source of data and trend analysis on the mergers and
acquisitions and financings in the medical equipment market. The report
provides detailed information on M&A, Equity/Debt Offerings, Private
Equity, Venture Financing and Partnership transactions registered in the
medical equipment industry in August 2009. The report portrays detailed
comparative data on the number of deals and their value in the last six
months subdivided by deal types, segments, and geographies.
Additionally, the report provides information on top financial advisory
firms in the medical equipment industry. Oct 2009
more ...
SynCardia’s companion driver system
for artificial heart receives CE Mark
SynCardia Systems, Companion Driver System has received CE Mark approval
to power the Total Artificial Heart in Europe. 20 Oct 2009
Cochlear and NXP Semiconductors
collaborate to produce IC devices for advanced hearing implants
The agreement includes the definition, development and supply of
ultra low power speech processor and wireless communication ICs to be
used in Cochlear’s next generation products. 20 Oct 2009
Serametrix Partners with the Ludwig Institute for Cancer Research
to develop and commercialize serum-based diagnostics
This new alliance will enable rapid development and commercialization of
tests that predict and monitor drug response in cancer patients. 20 Oct
2009
Baxter receives EC approval for
Celvapan H1N1 pandemic flu vaccine
Celvapan H1N1 is the first cell culture-based and non-adjuvanted
pandemic influenza vaccine to receive marketing authorization in the
European Union. 14 Oct 2009
Claros Diagnostics receives ISO
13485 certification for point-of-care blood-test system
Claros Diagnostics, a developer of novel point-of-care immunoassay
systems, has reported the receipt of corporate ISO 13485 and CMDCAS
certificates of registration issued by the National Standards Authority
of Ireland (NSAI). 14 Oct 2009
Corning increases lab portfolio
with acquisition of Axygen BioScience
Corning Incorporated has acquired all the shares of Axygen BioScience,
Inc. and its subsidiaries from American Capital Ltd. (Nasdaq:ACAS) for
approximately US$400 million in cash. 9 October 2009
French biotech companies seek UK
partners: BIOMED-Connect Oct 12, London
The London Branch of Maison de la Région Languedoc-Roussillon, with
support from the London Technology Network, is holding BIOMED-Connect, a
business convention, on Monday October 11th from 2.00pm to 9.00pm open
to all companies in the medical technology sector. 7 October 2009
Acrobot and Finsbury Orthopaedics
sign co-marketing agreement
Acrobot, a developer of computer-assisted orthopaedic surgery products
has announced a co-marketing arrangement with orthopaedic implants
company, Finsbury. 5 October 2009
AorTech licenses heart valve to
SynCardia for use in artificial heart
This agreement licenses the use of AorTech’s Elast-Eon polymer heart
valve (PHV) in the SynCardia Total Artificial Heart, as well as the
company’s future family of pulsatile products. 23 Sept 2009
Cardinal Health spin-off CareFusion
starts trading on NYSE
CareFusion Corp. was launched as an independent, publicly traded company
at the beginning of the month. CareFusion products include Pyxis
automated dispensing systems, Alaris IV pumps, ChloraPrep V. Mueller
surgical instruments. 21 Sept 2009
eBioscience corporation acquires
NatuTec GmbH
eBioscience Corporation, a San Diego-based producer of cell analysis
reagents to biotechnology laboratories has announced the acquisition of
Frankfurt-based NatuTec GmbH, a distributor of high-quality biological
research reagents. 21 Sept 2009.
Abbott to acquire cardiac valve
device company Evalve
The acquisition provides Abbott with a presence in the growing area of
non-surgical treatment for structural heart disease for a cost of up to
$410 million. 21 Sept 2009
IDRI licenses NanoPass microneedle
technology for intradermal delivery
IDRI has licensed NanoPass' proprietary MicronJet microneedle technology
for the intradermal delivery of products against a number of diseases
including tuberculosis, HIV, malaria, leishmaniasis and leprosy. 10 Sept
2009
NeuroLogica announces FDA clearance
for inSPira HD: portable high resolution SPECT
The inSPira HD is a battery-powered, high resolution, portable SPECT
designed primarily for brain imaging. 5 Sept 2009
GE Healthcare and TomTec Imaging
Systems co-operate in cardiology IT
GE Healthcare and TomTec Imaging Systems GmbH, have entered into a
formal strategic co-operation contract to improve their echocardiography
systems. 5 September 2009
Sectra signs multi-year contract
with Nordic region’s largest radiology company
Sectra and Norwegian company Curato have signed a six-year partnership
agreement for Sectra’s RIS/PACS products and services in a contract
worth about SEK 100 million.
Lab21 to provide AdnaGen’s tumour
cell detection system UK and Ireland
Lab21 Ltd and AdnaGen AG have entered into an exclusive service and
distribution agreement for AdnaGen’s proprietary circulating tumour cell
diagnostic assays in the United Kingdom and Ireland. 26 August 2009
Norway prepares for swine flu with
purchase of 150 Maquet ventilators
Maquet Nordic and Puls AS have announced that they have won a SEK15
million order from the Norwegian Health Authority (Helsedirektoratet)
for 140 of its Servo-i ventilators to supply hospitals across Norway
during August 2009. 26 August 2009
Siemens and Impac expand co-operation
in oncology information systems
The partnership will give Siemens customers access to Impac’s oncology
information system (OIS) will develop interfaces for their software to
interoperate. 20 August 2009
Deutsch
SonoSite completes acquisition of
CardioDynamics
CardioDynamics will become a wholly-owned subsidiary of SonoSite, Inc.
The transaction is valued at approximately $10.0 million. 20 August 2009
Universal flu vaccines to be
developed under Inovio and US Vaccine Research Center collaboration
The VRC and Inovio will pool technologies to develop the vaccines as
well as rapidly advance development of vaccine candidates targeting the
emerging pandemic 2009 H1N1 swine flu strains. 20 August 2009
Omnio Healer selects Eden Biodesign
for production of wound healing and anti-infection products
Eden Biodesign will provide process development and production services
for Omnio Healer’s wound healing and anti-infection products for
supplying the products for clinical trials. 20 August 2009
Ichor awarded US$3.3m grant to
develop DNA-based Alzheimer’s disease vaccine
Ichor Medical Systems of San Diego has been awarded the grant from the
US National Institute of Neurological Disorders and Stroke (NINDS) for
development of the vaccine and studies required to support eventual
initiation of human clinical testing. 20 August 2009
ImmunoVaccine Technologies partners
with Scancell to advance DNA vaccine delivery
Canadian company IVT has signed an agreement with UK-based Scancell Ltd
to explore the potential of using IVT's DepoVax delivery system for
Scancell's novel ImmunoBody DNA vaccines. 17 August 2009
Turkish Hospital Group orders four
RapidArc radiotherapy systems
Acibadem Healthcare Group has acquired four additional radiotherapy
treatment machines from Varian Medical Systems and expanded its
radiotherapy facilities with new centres in Adana and Kayseri. 17 August
2009
Sigma-Aldrich offers customisable
synthetic extracellular matrix for stem cell research
Under an agreement with Glycosan BioSystems, Sigma-Aldrich can offer the
HyStem platform for stem cell research. This consists of hydrogel cell
culture scaffolds that provide a complex, three-dimensional environment
in which cells are able to proliferate. 17 August 2009
LabCorp completes acquisition of
Monogram Biosciences. 9 August 2009.
Promega expands life science
products with takeover of Turner BioSystems. 9 August 2009
Leica Microsystems and A Menarini
Diagnostics extend distribution agreement
Leica Microsystems GmbH and A Menarini Diagnostics Srl have signed a
five-year agreement to extend their successful co-operation in
distributing Leica products in Europe. 7 August 2009
Covidien to acquire Power Medical
Interventions
Covidien has announced that the company has reached a definitive
agreement to acquire Power Medical Interventions, Inc. a provider of
computer-assisted, power-actuated surgical cutting and stapling
products, for approximately $64 million. 31 July 2009
Agilent Technologies to acquire
Varian for $1.5 billion
Varian, Inc has agreed to a takeover by Agilent Technologies Inc.
Agilent will pay $52 cash per share of common stock for Varian in a
transaction that represents a premium of approximately 35% to Varian’s
closing price on July 24, 2009. 29 July 2009
Industry experts in partnership to
stimulate UK medical technology sector
The team behind the UK Access to Finance for Healthcare Technology
Companies programme has today announced an alliance with two of the
leading organisations in the regional medical technology sector. 2 July
2009
Rubicon Genomics introduces
PicoPlex single cell whole genome amplification kit. 2 July 2009
BioSante Pharmaceuticals and Cell
Genesys sign merger agreement. 2 July 2009
GE Healthcare and Geron in global
agreement to commercialize stem cell drug discovery technologies. 2
July 2009
GlaxoSmithKline signs contract for
Phase Forward clinical trials software. 2 July 2009
Nucletron strengthens position in
cancer radiation therapy market
Dutch radiation therapy systems company Nucletron BV has announced the
creation of an exclusive partnership and plan to merge with sector peer
Isodose Control BV. 29 June 2009
Vivacta raises US$4.5 million to
commercialise piezofilm technology for point-of-care diagnostic tests
Kent-based diagnostic technology company Vivacta has announced that
following successful development of its thyroid function test, it has
closed a financing round that was fully subscribed by existing
investors. 18 June 2009
Aircraft Medical acquires
anaesthesia monitoring technology from Morpheus Medical
Morpheus' lead product, the IoC-View, is designed to measure the level
of consciousness during general anaesthesia, helping to avoid the risk
of patients remaining conscious during surgery. 17 June
European medical technology sector
weathering storm but expecting tougher times
A recent survey by Eucomed of medical technology manufacturers across
Europe has found that the recession was having a significant negative
impact on only 20% of the companies. 8 June 2009
Deutsch
Francais Español
Medtronic and Lilly partner to
improve delivery of diabetes education
Medtronic and Eli Lilly have entered a strategic marketing collaboration
to support each other's commitment to help people with diabetes manage
their blood sugar using insulin therapy. 5 June 2009
Oxford Biosensors placed in
administration following funding withdrawal
Biotech Company, Oxford Biosensors has been put up for sale following
the appointment of administrators. The company has developed unique
technology for point-of-care electrochemical testing for lipids and
other analytes, for use in the cholesterol, diabetes and renal function
diagnostic testing markets. 4 June 2009
Nanogen enters asset purchase
agreement with Elitech and files for bankruptcy
Nanogen, Inc., developer of molecular and rapid diagnostic products, has
executed an asset-purchase agreement with French company Elitech Group,
a privately held diagnostics company, to acquire substantially all of
the assets of Nanogen. 28 May 2009
RaySearch enters partnership with
Siemens
Swedish company RaySearch Laboratories AB has entered into a long-term
development and licensing agreement with Siemens Healthcare in which
RaySearch will provide a number of treatment planning modules that will
be integrated in Siemens’ syngo Suite for Oncology. 28 May 2009
Thin-film battery revenues to come
from medical devices, sensors and watches
Thin-film batteries are being designed as energy storage devices for
small photovoltaic or thermoelectric systems to create ultra-long-lived
power sources for medical devices, sensors and watches. 19 May 2009
Biotech business model
unsustainable in current economic crisis
The global biotechnology industry delivered a solid financial
performance in 2008 despite worldwide economic turmoil, according to
Ernst & Young's 23rd annual report on the biotech industry. 19 May 2009
GE commits US$6bn to healthcare
innovation
GE has announced a US$3 billion budget for the next six years for
healthcare innovation, a further US$2 billion of financing and US$1
billion in related GE technology and content to drive healthcare
information technology and health in rural and underserved areas. 11 May
2009
Phase Forward signs agreement with
Novo Nordisk for use of InForm for clinical trial data capture
The multi-million dollar agreement allows Danish company Novo Nordisk to
use Phase Forward’s InForm electronic data capture product across all
clinical trial phases, from Phases I through IV. 7 May 2009
PerkinElmer becomes exclusive
distributor for ID Biological Systems’ newborn screening sample
collection cards. 7 May 2009
Major Portuguese hospital selects
Sectra to provide PACS
Hospital de São João, one of Portugal’s largest hospitals, has selected
Sectra to provide picture archiving and communications (PACS) products
and services in a multi-year contract. 7 May 2009
St Jude Medical gains EU approval
for remote care system for implantable cardiac devices
St Jude Medical's Merlin.net Patient Care Network (PCN) is a secure,
Internet-based remote care system that gathers and stores data from the
implant procedure, a clinic follow-up visit or from remote follow-up
transmissions of patients with implanted cardiac devices. 7 May
iSOFT wins €600,000 HIS contract in
Italy
IBA Health Group Limited has announced that iSOFT has entered the
Italian market with a €600,000 contract to install its hospital
information system in four hospitals operated by Consorzio Regionale
Servizi Sociali (CRESS), a private healthcare group. 6 May 2009
Philips acquires Canadian minimally
invasive instrument supplier Traxtal
Royal Philips Electronics has announced that it has acquired
Canada-based Traxtal Inc., Traxtal will become part of the Ultrasound
business within the Philips Healthcare sector. 6 May 2009
SCM Microsystems completes merger
with Hirsch Electronics
SCM Microsystems, Inc. based in Ismaning, Germany, has announced that it
has closed its merger with Hirsch Electronics Corp. Hirsch is now a
wholly-owned subsidiary of SCM. 6 May 2009
Gemalto joins SAFE-BioPharma
Association
Gemalto is joining with biopharmaceutical and healthcare industry
leaders to help the industry achieve its common goal of a fully
electronic business environment by 2012. 23 April 2009
Rigel Pharmaceuticals and Proteros
extend research collaboration
The collaboration gives Rigel access to Proteros’ Gallery Structures
enabling Rigel to rapidly deliver high quality protein-ligand structural
information. 23 April 2009
Parabon NanoLabs to use power of grid computing to design novel
macromolecules based on synthetic DNA
Parabon Computation has spun off Parabon NanoLabs to develop nano-scale products based on designer DNA technology.
It will initially focus on developing nano-scale sensors for
therapeutics, diagnostics and other molecular detection systems.
9 April 2009
Cardima surgical ablation probe
receives EU approval
Cardima, Inc. has received CE Mark approval for its Surgical Ablation
Probe with Stabilization Sheath. The system can be used in open-chest
surgery in conjunction with other procedures, or as a thoroscopic
standalone, closed-chest procedure. 9 April 2009
BioAdvance Greenhouse invests
$550,000 in Novira Therapeutics' antiviral drug technology
Novira is focused on the development of novel small-molecule drugs
against medically-important viral targets. 8 April 2009
AtriCure’s cryoablation system receives
US FDA clearance.
AtriCure's disposable cryoablation system, Cryo1, received 510(k) clearance from the US FDA
for the cryosurgical treatment of cardiac arrhythmias. 8 April 2009
Physio-Control receives US
clearance for Lifepak 15 monitor/defibrillator. 8 April 2009
OrSense receives EU approval for
non-invasive haemoglobin and pulse oximetry monitoring system
OrSense Ltd has received a European CE Mark for its NBM-200MP, a
multi-parameter sensor for non-invasive continuous hemoglobin, low
signal oximetry and pulse rate measurements. 8 April 2009
Genedata strengthens TcLand
Expression’s research informatics infrastructure for personalized
medicine. 8 April 2009
AVEO and Biogen Idec in partnership
to develop ErbB3-targeted antibodies. 8 April 2009
Aphios collaborates with VivaCell
Biotechnology España to develop combination therapy for HIV latency.
8 April 2009
FluGen secures exclusive rights to
novel vaccine-delivery technology
Flugen Inc., has secured rights to vaccine-delivery technology being
commercialized by Ratio Inc. The easy-to-use, disposable micro-device
painlessly delivers seasonal and pandemic influenza vaccines. 7 April
2009
Gene Bridges licenses recombineering
technology to Daiichi Sankyo
Heidelberg-based Gene Bridges GmbH, has licenced its Red/ET
recombination technology to Japanese company Daiichi Sankyo. 7
April 2009
Intel and GE form $250m alliance to
develop home healthcare technology
GE and Intel Corporation have entered into an alliance to market and
develop home-based health technologies that will help the elderly live
independently and patients with chronic conditions manage their care at
home. 6 April 2009
German medical technology sector
withstanding economic crisis
Only 4% of companies in the German medical technology sector have
reduced their workforce as a result of the global financial crisis,
according to a survey conducted by the German Medical Technology
Association, BVMed. 27 March 2009
Smart Cells establishes base in Italy
London-based Smart Cells International, the UK's longest-established
cord blood stem cell processing and storage organisation, has
established a base in Milan, Italy, with a joint venture with Laborest,
one of Italy's leading pharmaceutical businesses. 25 March 2009
Systech to integrate serialisation
expertise with Axway’s track and trace system
Axway and Systech International will partner to offer integrated systems
for pharmaceutical supply chain integrity to ensure customer readiness
for upcoming European and Turkish regulatory compliance. 25 March 2009
Domainex in collaboration to develop
novel breast cancer drug targets
Domainex has announced a collaboration on drug-discovery programmes with
the Breakthrough Breast Cancer Research Centre and The UK Institute of
Cancer Research to identify and develop inhibitors of two recently
validated breast cancer targets, tankyrase and IKK-epsilon. 23 March
German healthcare group selects Varian
linear accelerators for radiotherapy
The HELIOS Kliniken Group is acquiring nine linear accelerators from
Varian Medical Systems (NYSE: VAR), the majority of them equipped with
RapidArc technology. The new machines will replace older models and add
capacity that will give more patients access to the most advanced cancer
care. 23 March 2009
Touch Bionics’ founder steps down
Touch Bionics, developer of the world’s first commercially available
bionic hand, has announced that Director of Research and Non Executive
Director, David Gow, was stepping down from the business to concentrate
on his expanding role within NHS Lothian’s SMART Centre in Edinburgh. 17
March 2009
Siemens obtains full rights to the i.s.h.med
hospital information system
Siemens Medical Solutions is taking over all use and exploitation rights to the
software i.s.h.med, a clinical information system integrated with the
SAP healthcare software. The system was jointly developed by the partner
and forerunner companies of Siemens Medical Solutions GSD GmbH and the
Austrian T-Systems. Deutsch
St Jude Medical receives EU approval
for neurostimulation system for chronic angina
St Jude Medical's Genesis neurostimulation system is for managing a form
of chest pain known as chronic angina pectoris, or chronic angina. It
helps to control angina pain by sending mild pulses of electricity from
a device implanted in the torso to nerves located along the spinal cord.
12 March 2009
Dräger receives double design award
for medical devices
Two Dräger products have received the iF product design award in 2009:
The Ponta beam system and the Infinity C700 for IT workstation. The iF
product design award is one of the most important design competitions
worldwide. 12 March 2009
StemCells to acquire drug discovery
technology of Stem Cell Sciences
StemCells, Inc. is to acquire the operating subsidiaries and certain
related assets of Stem Cell Sciences (SCS), a Cambridge, UK-based
company focused on commercializing applications of stem cell
technologies for drug discovery and regenerative medicine research. 10
March 2009
Lab21 acquires Biotec Laboratories
Lab21 Ltd of Cambridge, UK, has announced that it has purchased the
majority shareholding of another UK company Biotec Laboratories Ltd, a
clinical diagnostic company with particular emphasis on infectious
diseases. 10 March 2009
Michelson Diagnostics raises £350K for
clinical trials and growth
The money will be used to support multi-centre clinical trials of its
new hand-held multi-beam optical coherence tomography (OCT) imaging
probe, and also aid international commercial growth. 4 March 2009
Yorkshire attracts major investment in
healthcare technologies
The Yorkshire and Humber region in northeast England has accounted for
nearly 10% of first-round investments in healthcare technology in the
UK, according to figures revealed at the launch of a new Access to
Finance programme for local healthcare technology companies. 2 March
2009
Abbott completes takeover of Advanced
Medical Optics
Abbott has announced that it has completed its acquisition of Advanced
Medical Optics (AMO), which is now a wholly owned subsidiary of Abbott
with the new name Abbott Medical Optics Inc. 2 March 2009
Sciemetric wins major quality control
contract in medical device sector
Sciemetric Instruments, a supplier of manufacturing quality systems has
been named a preferred supplier to one of the world’s largest medical
device manufacturers, cementing its position in a key growth market for
the company. 27 February 2009
APR acquires new drug delivery
nanotechnology for innovative treatment of critical diseases
Swiss company Applied Pharma Research s.a. (APR) has acquired a
nanocoating process for the preparation of new products for the
treatment of several critical diseases. APR is already developing
specific applications in ophthalmology and dermatology. 22 February 2009
Varian receives European approval for
proton therapy system
Proton therapy allows doctors to use higher doses of radiation to
control and manage tumours while significantly reducing damage to
healthy tissue and vital organs. 22 February 2009
Symphogen secures €33m financing to
support clinical development of antibody products
Copenhagen-based Symphogen A/S has announced the closing of €33 million
(approximately US $44 million) financing. The financing will be used to
mature the company’s product pipeline of antibody therapeutics,
particularly within the field of oncology. 16 February 2009
Millipore acquires Guava Technologies
Millipore Corporation (NYSE: MIL), a leading provider of technologies,
tools and services for the global life science industry, has entered
into an agreement to acquire Guava Technologies, a provider of
easy-to-use, bench top cell analysis systems. 16 February 2009
Mirna Therapeutics and UCSF to explore
therapeutic potential of microRNAs
Mirna Therapeutics and the University of California, San Francisco
have entered into a collaboration agreement to evaluate the capacity of
specific microRNAs to reduce or eliminate tumours in mouse models of
cancer. 16 February 2009
Masimo files lawsuit against Philips
for pulse oximetry patent infringement. 16 February 2009
Expression Analysis in partnership
with Complement Genomics to offer genomic services in UK. 16
February 2009
Response Genetics closes UK facility
Response Genetics has announced that it is closing its Edinburgh, UK
facility and increasing the capacity of its genetic testing laboratory
in Los Angeles, USA. 16 February 2009
International collaboration to develop
ultrasound-activated drug-delivery nanoparticles
Nanobiotix, an emerging nanomedicine company has announced that it will
collaborate with the SonoDrugs project consortium to develop new
nanoparticulate drug carriers that can be activated for localized drug
release using focused ultrasound. 10 February 2009
Sysmex in agreement to distribute
AdnaGen cancer diagnostic tests in Europe
Sysmex Europe GmbH and AdnaGen AG have entered into a non-exclusive
European distribution agreement for AdnaGen proprietary CE-certified
diagnostics as well as their research use only (RUO) products. 10
February 2009
EXACT Sciences in strategic
relationship with Genzyme for DNA diagnostics technology
Genzyme has acquired intellectual property assets related to prenatal
and reproductive health and three million shares of EXACT common stock
for $24.5 million. 9 February 2009
FORMA to collaborate with Cubist to
develop novel antibacterial drugs
FORMA Therapeutics has signed a collaboration agreement with Cubist
Pharmaceuticals, Inc. to leverage FORMA’s transformative chemistry
platform to discover novel antibacterial compounds for development by
Cubist. 9 February 2009
IAVI and Algonomics to collaborate on HIV protein design project
The International AIDS Vaccine Initiative (IAVI) and Belgian company
Algonomics have announced a collaboration to develop novel vaccine
candidates capable of controlling HIV infection.
9 February 2009
Tomotherapy radiation treatment
planning software gains FDA clearance
Swedish company RaySearch Laboratories AB and TomoTherapy Inc have
announced that their jointly produced new software solution for the
Tomotherapy Hi-Art linear accelerator has received clearance by the FDA
for market launch in the US. 9 February 2009
Pfizer to acquire Wyeth for $68bn
Pfizer and Wyeth have
entered into a definitive merger agreement under which Pfizer will
acquire Wyeth in a cash-and-stock transaction worth approximately $68
billion. 4 February 2009
Graffinity and Elan in fragment-based
drug-discovery collaboration
Under the terms of the agreement, Graffinity will receive technology
access fees and success payments for the generation of novel small
molecule hits against a number of drug targets. 4 February 2009
Ontario grants Agfa Healthcare
$29.6-million to create jobs for developing radiology software
The award is to help create 100 new jobs and support existing jobs by
supporting Agfa in the development of new software that allows
radiologists to share digital images across a regional network. 31
January 2009
Johnson & Johnson joins Enlight
Biosciences in US$52 million in novel drug discovery initiative
As a partner, Johnson & Johnson will have the opportunity to invest in
the development of strategic technologies that have the potential to
fundamentally transform drug discovery. 31 January 2009
Richter-Helm and Athera
Biotechnologies in partnership to develop recombinant protein for
cardiovascular disease
The partnership will develop and manufacture Athera's novel product for
prevention of plaque rupture and athero-thrombosis through binding of
the protein, Annexin A5, to endothelium. 31 January 2009
Allium Group receives CE Mark for
next-generation prostatic stent
Allium Group has announced that it has been awarded CE mark for its
prostatic stent, enabling commercialization of the system in the
European Union and the countries that recognize the CE Mark. 31 January
2009
Philips collaborates with Bard
Electrophysiology to advance cardiac arrhythmia treatment
Royal Philips Electronics has announced an agreement with Bard
Electrophysiology to co-develop new clinical tools to help
electrophysiologists treat patients suffering from arrhythmias. 31
January 2009
Vivacta achieves ISO13485 for quality
management
Vivacta has announced that it has achieved compliance with ISO13485, an
important step towards the successful commercialisation of its
ultrasensitive point-of-care immunochemistry system. 31 January 2009
Crospon receives CE Mark for EndoFLIP
System
Irish medical device developer Crospon has announced that its EndoFLIP
system has received CE Mark certification from the NSAI (National
Standards Authority of Ireland), the Irish Notified Body, in accordance
with the European Medical Device Directive. 31 January 2009
St Jude's Libra deep brain stimulation
systems for Parkinson’s disease gains EU approval
St Jude Medical has received the European CE Mark approval for its Libra
and LibraXP deep brain stimulation (DBS) systems, the company's first
products in the DBS market. 31 January 2009
e-Therapeutics enters drug discovery
partnership with Cresset BioMolecular Discovery
e-Therapeutics plc (AIM: ETX) has entered into an agreement with
UK-based Cresset BioMolecular Discovery Ltd, a specialist in molecular
field technology. The initial focus of the collaboration will combine
e-Therapeutics’ computational platform with Cresset’s advanced
technology in chemical comparison. 27 January 2009
Morphotek in evaluation agreement with
University Hospital Heidelberg
The evaluation will advance the company's efforts in the discovery and
development of therapeutic antibodies in oncology. 25 January 2009
Michelson Diagnostics singled out as
high-growth company
UK-based Michelson Diagnostics has been singled out as a company with
high growth potential by two leading investor organisations. 25 January
2009
New Venture Partners and Unilever
Ventures invest in personalised weight management system
New Venture Partners LLC, the global venture capital firm dedicated to
corporate technology spinouts, and Unilever Ventures, the early stage
venture arm of Unilever, have jointly invested in MiLife, a company
focused on providing technology solutions for personalised weight
management. 25 January 2009
UK healthcare technology companies
urged to tap into growing Middle East markets
UK Trade & Investment (UKTI) and the Association of British Healthcare
Industries (ABHI) are urging UK healthcare technology businesses to
capitalise on demand in the fast growing Middle East market. 23 January
2009
ICON completes takeover of Beacon
Bioscience
Dublin-based ICON plc has completed the acquisition of the remaining 30%
shareholding of Beacon Bioscience Inc. 22 January 2009
Boston Scientific acquires Labcoat's
stent technology
Boston Scientific Corporation has acquired Labcoat Limited, a privately
held, development-stage drug-eluting stent technology company located in
Galway, Ireland. Terms of the acquisition were not disclosed. 16 January
2009
Sigma-Aldrich acquires Seppro
depletion technology from GenWay Biotech
Sigma-Aldrich has expanded its proteomics offerings with the acquisition
of Seppro affinity depletion technology and a library of 700
avian-derived antibodies from GenWay Biotech, Inc. Seppro depletion
products enable scientists to measure more precisely the expression of
protein biomarkers from a range of mammalian and plant biological
samples. 16 January 2009
ExonHit Therapeutics expands strategic
collaboration with Allergan
ExonHit Therapeutics has announced a reinforcement of its existing drug
discovery collaboration with Allergan Sales. The collaboration includes
antibody discovery within the scope of the research activities and
encompasses revised commercial terms. 16 January 2009
PerkinElmer launches Operetta high
content screening system
PerkinElmer, Inc., has launched its Operetta system, a benchtop
instrument that provides high content screening (HCS) and high content
analysis (HCA) capabilities to drug discovery and cellular science
research laboratories.
Abbott acquires Ibis Biosciences
Abbott has exercised its option to purchase the remaining equity
ownership in Ibis Biosciences, Inc., an Isis subsidiary, for a closing
purchase price of $175 million. 12 January 2009
CMPMedica signs global contract with
iSOFT for drug information decision support tools
CMPMedica's information solution will power iSOFT's suite of
decision-support tools. These tools enable healthcare professionals to
make better informed decisions at the point of care and thus improve
patient outcomes. 9 January 2009
AorTech signs licensing agreement for
medical device components
AorTech International plc has announced a technology license and
material supply agreement with a leading manufacturer of a
life-sustaining circulatory support system. 9 January 2009
Agfa wins contract from Antwerp
University Hospital for cardiovascular system
Antwerp University Hospital, Belgium, has awarded Agfa HealthCare a
contract for its IMPAX Cardiovascular solution. The contract will
provide enterprise-wide access to cardiology patient records to meet the
high volume diagnostic needs. 6 January 2009
Business news: Now
| 2008
| 2007 |
2006 | 2005
To top
|